Pub Date : 2022-07-01DOI: 10.1097/JDN.0000000000000692
D. Panikkath, V. Sandhu
ABSTRACT Inflammation driven by immune-mediated mechanisms can lead to a wide variety of skin manifestations. Cutaneous lupus erythematosus (CLE), for example, is an autoimmune connective tissue disease that may be limited to the skin or be part of the widespread multiorgan involvement seen in systemic lupus erythematosus. Clinical findings are divided into lupus-specific (acute, subacute, and chronic) and nonspecific skin lesions. The diagnosis of CLE requires a thorough physical examination and, in some cases, skin biopsy and laboratory evaluation for any underlying systemic involvement. CLE treatment is dependent on the cutaneous manifestations and severity of disease. In addition to lifestyle measures, particularly avoidance of sunlight, topical and systemic therapies have proven beneficial. Prognosis is varied by disease severity, although chronic CLE notoriously results in cosmetic damage. Early recognition and management of CLE is important as it may also be the presenting manifestation of systemic lupus erythematosus. Patient care includes education and close collaboration with primary care providers, dermatologists, and rheumatologists.
{"title":"Cutaneous Manifestations of Systemic Lupus Erythematosus","authors":"D. Panikkath, V. Sandhu","doi":"10.1097/JDN.0000000000000692","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000692","url":null,"abstract":"ABSTRACT Inflammation driven by immune-mediated mechanisms can lead to a wide variety of skin manifestations. Cutaneous lupus erythematosus (CLE), for example, is an autoimmune connective tissue disease that may be limited to the skin or be part of the widespread multiorgan involvement seen in systemic lupus erythematosus. Clinical findings are divided into lupus-specific (acute, subacute, and chronic) and nonspecific skin lesions. The diagnosis of CLE requires a thorough physical examination and, in some cases, skin biopsy and laboratory evaluation for any underlying systemic involvement. CLE treatment is dependent on the cutaneous manifestations and severity of disease. In addition to lifestyle measures, particularly avoidance of sunlight, topical and systemic therapies have proven beneficial. Prognosis is varied by disease severity, although chronic CLE notoriously results in cosmetic damage. Early recognition and management of CLE is important as it may also be the presenting manifestation of systemic lupus erythematosus. Patient care includes education and close collaboration with primary care providers, dermatologists, and rheumatologists.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90270854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-07-01DOI: 10.1097/jdn.0000000000000696
Oyindayo M. Hassan, V. Medepalli, Daniel P. Zieman, Joshua R. Ortego, R. Brodell, V. Nahar
{"title":"Translucent Cyst Around the Eyelid","authors":"Oyindayo M. Hassan, V. Medepalli, Daniel P. Zieman, Joshua R. Ortego, R. Brodell, V. Nahar","doi":"10.1097/jdn.0000000000000696","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000696","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79119284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-07-01DOI: 10.1097/jdn.0000000000000700
Angela L. Borger
{"title":"Conference 2022, The Sequel","authors":"Angela L. Borger","doi":"10.1097/jdn.0000000000000700","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000700","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79794432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-07-01DOI: 10.1097/jdn.0000000000000699
{"title":"Skin Cancer in People of Color: Misconceptions and Opportunities for Early Detection and Treatment","authors":"","doi":"10.1097/jdn.0000000000000699","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000699","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87579377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-29DOI: 10.1097/JDN.0000000000000697
Jarett D Anderson, A. Hamp, Alisha Booms, Kimberly Carlson Stover
ABSTRACT Melanoma in situ (MIS) is considered a noninvasive precursor to malignant melanoma and is defined as abnormal melanocytes that are confined to the epidermis without evidence of invasion through the basal membrane and into the deeper dermis. It is often referred to as Stage 0 melanoma. MIS is thought to have no metastatic potential. However, several reports have shown that occult invasive disease may be found upon further testing of pathologically unequivocal MIS. In addition, several risk factors contribute to the upstaging of an MIS. We present a case of a patient who was diagnosed with MIS who underwent excision of the primary lesion. Although the pathology report of the excision revealed negative margins, he was later found to have metastatic lesions to several lymph nodes, his parotid gland, and his brain. This resulted in extensive medical treatment that the patient did not originally anticipate.
原位黑色素瘤(Melanoma in situ, MIS)被认为是恶性黑色素瘤的一种非侵入性前体,被定义为局限于表皮的异常黑色素细胞,没有通过基膜侵入真皮深层的迹象。它通常被称为0期黑色素瘤。MIS被认为没有转移潜力。然而,一些报告显示,在病理明确的MIS进一步检测后,可能会发现隐匿的侵袭性疾病。此外,有几个风险因素会导致管理信息系统被抢占先机。我们提出一个病例的病人谁被诊断为MIS谁接受原发病变切除。虽然病理报告显示切除的边缘为阴性,但后来发现他的几个淋巴结、腮腺和大脑有转移性病变。这导致了病人最初没有预料到的广泛的医疗。
{"title":"Metastasis of a Surgically Excised Melanoma In Situ","authors":"Jarett D Anderson, A. Hamp, Alisha Booms, Kimberly Carlson Stover","doi":"10.1097/JDN.0000000000000697","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000697","url":null,"abstract":"ABSTRACT Melanoma in situ (MIS) is considered a noninvasive precursor to malignant melanoma and is defined as abnormal melanocytes that are confined to the epidermis without evidence of invasion through the basal membrane and into the deeper dermis. It is often referred to as Stage 0 melanoma. MIS is thought to have no metastatic potential. However, several reports have shown that occult invasive disease may be found upon further testing of pathologically unequivocal MIS. In addition, several risk factors contribute to the upstaging of an MIS. We present a case of a patient who was diagnosed with MIS who underwent excision of the primary lesion. Although the pathology report of the excision revealed negative margins, he was later found to have metastatic lesions to several lymph nodes, his parotid gland, and his brain. This resulted in extensive medical treatment that the patient did not originally anticipate.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72366174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-24DOI: 10.1097/jdn.0000000000000693
Katherine D. Shue-McGuffin, Kelly Powers
{"title":"Skin Cancer in People of Color","authors":"Katherine D. Shue-McGuffin, Kelly Powers","doi":"10.1097/jdn.0000000000000693","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000693","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84583320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-11DOI: 10.1097/jdn.0000000000000691
Ariel Park, Cynthia Serabyn
{"title":"Crusted Keratotic Exophytic Nodule on the Lower Lip","authors":"Ariel Park, Cynthia Serabyn","doi":"10.1097/jdn.0000000000000691","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000691","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81154459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-06DOI: 10.1097/JDN.0000000000000694
Jason Gomez, S. Admani
ABSTRACT Dermal melanocytosis includes a spectrum of benign diseases, including congenital dermal melanocytosis, nevus of Ota, and nevus of Ito. Congenital dermal melanocytosis is blue–gray pigmentation typically on the lumbar or sacral regions. Affected areas outside the lumbar or sacral region are less likely to fade with time. Nevus of Ota is usually a unilateral blue–gray pigmentation change of the face in the distribution of the first and second divisions of the trigeminal nerve. It persists lifelong and can be complicated by ocular melanoma. Nevus of Ito is similar to Nevus of Ota in that it persists lifelong but differs in its location. Nevus of Ito primarily affects the supraclavicular, deltoid, or scapular regions. In select cases, dermal melanocytosis can be treated with cosmetic cover-ups and lasers that target melanin.
{"title":"Dermal Melanocytosis","authors":"Jason Gomez, S. Admani","doi":"10.1097/JDN.0000000000000694","DOIUrl":"https://doi.org/10.1097/JDN.0000000000000694","url":null,"abstract":"ABSTRACT Dermal melanocytosis includes a spectrum of benign diseases, including congenital dermal melanocytosis, nevus of Ota, and nevus of Ito. Congenital dermal melanocytosis is blue–gray pigmentation typically on the lumbar or sacral regions. Affected areas outside the lumbar or sacral region are less likely to fade with time. Nevus of Ota is usually a unilateral blue–gray pigmentation change of the face in the distribution of the first and second divisions of the trigeminal nerve. It persists lifelong and can be complicated by ocular melanoma. Nevus of Ito is similar to Nevus of Ota in that it persists lifelong but differs in its location. Nevus of Ito primarily affects the supraclavicular, deltoid, or scapular regions. In select cases, dermal melanocytosis can be treated with cosmetic cover-ups and lasers that target melanin.","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82999617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-01DOI: 10.1097/jdn.0000000000000681
V. Medepalli, Collins Langley, Chelsea S. Mockbee, R. Brodell, V. Nahar
{"title":"Yellow Plaques Around the Eyes","authors":"V. Medepalli, Collins Langley, Chelsea S. Mockbee, R. Brodell, V. Nahar","doi":"10.1097/jdn.0000000000000681","DOIUrl":"https://doi.org/10.1097/jdn.0000000000000681","url":null,"abstract":"","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82422467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-05-01DOI: 10.1097/jdn.0000000000000682
Dawn M Holman, Karen Glanz, Amy Jordan, Amy Bleakley, Sabitha Dasari
This study examines beliefs about sunscreen use among non-Hispanic white adults aged 50 years or older using online survey data (n=237). Multiple logistic regression analyses were conducted to examine beliefs associated with sunscreen use, adjusted by age, gender, education, geographic location, and skin cancer risk score. Those who believed sunscreen use would prevent them from getting sunburned (odds ratio [OR]=1.84) and those who believed that their romantic partners thought they should use sunscreen (OR=1.72) were more likely to report sunscreen use. Those who believed sunscreen use would "take too much time" were less likely to report sunscreen use (OR=0.65). These findings can inform future research and messaging efforts, including the evaluation of intervention approaches that highlight the immediate benefits of sunscreen use, address concerns about sunscreen use taking too much time, and tap into the potential influence that older adults may have on the sunscreen use of their romantic partners.
{"title":"Beliefs Associated with Sunscreen use among non-Hispanic white Older Adults.","authors":"Dawn M Holman, Karen Glanz, Amy Jordan, Amy Bleakley, Sabitha Dasari","doi":"10.1097/jdn.0000000000000682","DOIUrl":"10.1097/jdn.0000000000000682","url":null,"abstract":"<p><p>This study examines beliefs about sunscreen use among non-Hispanic white adults aged 50 years or older using online survey data (n=237). Multiple logistic regression analyses were conducted to examine beliefs associated with sunscreen use, adjusted by age, gender, education, geographic location, and skin cancer risk score. Those who believed sunscreen use would prevent them from getting sunburned (odds ratio [OR]=1.84) and those who believed that their romantic partners thought they should use sunscreen (OR=1.72) were more likely to report sunscreen use. Those who believed sunscreen use would \"take too much time\" were less likely to report sunscreen use (OR=0.65). These findings can inform future research and messaging efforts, including the evaluation of intervention approaches that highlight the immediate benefits of sunscreen use, address concerns about sunscreen use taking too much time, and tap into the potential influence that older adults may have on the sunscreen use of their romantic partners.</p>","PeriodicalId":17315,"journal":{"name":"Journal of the Dermatology Nurses' Association","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724642/pdf/nihms-1784290.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9734669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}